Involvement of lysosomal proteins in morphology-driven toxicity of (nano)fibers - Top-Institutions - MDSpire

Involvement of lysosomal proteins in morphology-driven toxicity of (nano)fibers

  • By

  • Rico Ledwith

  • Carla Ribalta

  • Mario Pink

  • Andrea Haase

  • Verónica I. Dumit

  • July 14, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    CDC/NIOSH – Health Effects Laboratory Division (HELD) and Nanotechnology Research Center (NTRC)
    CDC/NIOSH – Health Effects Laboratory Division (HELD) and Nanotechnology Research Center (NTRC)

    Morgantown, West Virginia

    Key Differentiators

    • Nanotoxicology
    • Occupational Health

  • #2

    Harvard T.H. Chan School of Public Health – Center for Nanotechnology and Nanotoxicology
    Harvard T.H. Chan School of Public Health – Center for Nanotechnology and Nanotoxicology

    Boston, Massachusetts

    Key Differentiators

    • Nanotoxicology
    • Environmental Health

Original Source(s)

Involvement of lysosomal proteins in morphology-driven toxicity of (nano)fibers

  • by Rico Ledwith, Carla Ribalta, Mario Pink, Andrea Haase, Verónica I. Dumit

  • July 14, 2026

Related Content

Risk stratification model based on estimated dose of radiation to immune cells and radiotherapy-related nadir lymphocyte count for predicting the efficacy of consolidation immunotherapy in stage III non-small cell lung cancer

Correction: Clinical benefit and safety of immunotherapy beyond progression in advanced and locally advanced lung cancer: a real-world cohort study

Therapeutic inhibition of RAS in non-small cell lung cancer